LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 126 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 4.22 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $3,380,000 | -37.8% | 509,000 | 0.0% | 0.05% | -27.8% |
| Q3 2018 | $5,431,000 | +21.7% | 509,000 | +36.8% | 0.07% | +1.4% |
| Q2 2018 | $4,464,000 | +94.3% | 372,000 | +38.8% | 0.07% | +82.1% |
| Q1 2018 | $2,297,000 | -13.3% | 268,000 | 0.0% | 0.04% | -15.2% |
| Q4 2017 | $2,648,000 | -26.5% | 268,000 | -8.5% | 0.05% | -27.0% |
| Q3 2017 | $3,601,000 | -25.3% | 293,000 | 0.0% | 0.06% | -30.8% |
| Q2 2017 | $4,820,000 | +29.3% | 293,000 | +12.7% | 0.09% | +26.4% |
| Q1 2017 | $3,729,000 | +38.3% | 260,000 | +33.3% | 0.07% | +16.1% |
| Q4 2016 | $2,697,000 | -23.5% | 195,000 | 0.0% | 0.06% | -27.1% |
| Q3 2016 | $3,524,000 | +91.8% | 195,000 | +52.3% | 0.08% | +77.1% |
| Q2 2016 | $1,837,000 | +1.0% | 128,000 | -16.3% | 0.05% | +6.7% |
| Q1 2016 | $1,818,000 | -17.2% | 153,000 | -7.3% | 0.04% | -23.7% |
| Q4 2015 | $2,196,000 | – | 165,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $78,084,000 | 100.00% |
| Artal Group S.A. | 57,517,977 | $1,039,349,000 | 20.58% |
| NEA Management Company, LLC | 2,382,286 | $43,048,000 | 1.93% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $645,000 | 1.72% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 809,666 | $14,631,000 | 0.67% |
| MOODY ALDRICH PARTNERS LLC | 42,180 | $762,000 | 0.53% |
| Cupps Capital Management, LLC | 62,549 | $1,130,000 | 0.49% |
| BRIDGER MANAGEMENT, LLC | 336,966 | $6,089,000 | 0.41% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 258,353 | $4,668,000 | 0.34% |
| Round Table Services, LLC | 21,611 | $391,000 | 0.23% |